Internal Medicine, Endocrinology, Diabetes, & Metabolism · York, PA
NPI
1770512360
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
292 Saint Charles Way
York, PA, 17402
Phone (717) 851-6231
Groups this clinician bills Medicare through
Medicare paid, 2024
$132K
6,221 services
Medicare patients, 2024
372
Average age 73
Drug cost, 2024
$1.5M
3,768 prescriptions
Company payments, 2025
$18.52
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Alpa P Patel was code J0897 (injection, denosumab, 1 mg), 3,120 times for 37 patients. In total Alpa P Patel billed 6,221 services in 12 codes, and Medicare paid $132K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-05-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 3,120 | 37 | $20.47 | $64K |
| 99214 Office E&M - Established | Office | 406 | 302 | $86.43 | $35K |
| 95251 Test - Miscellaneous | Office | 286 | 115 | $24.49 | $7,004 |
| 99215 Office E&M - Established | Office | 95 | 83 | $130.80 | $12K |
| 96372 Injection Administration | Office | 76 | 42 | $10.70 | $813 |
| 99205 Office E&M - New | Office | 21 | 21 | $140.51 | $2,951 |
| 99204 Office E&M - New | Office | 12 | 12 | $76.09 | $913 |
By year: 2022 $103K for 8,341 services; 2023 $109K for 4,113 services; 2024 $132K for 6,221 services.
Medicare prescription drug claims, 2024
In 2024, the drug Alpa P Patel prescribed most often to Medicare patients was Levothyroxine Sodium, with 450 prescriptions and refills. In total Alpa P Patel wrote 3,768 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 450 | 1,269 | 132 | $4,728 |
| Ozempic Semaglutide | 281 | 451 | 59 | $407K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 254 | 613 | 86 | $27K |
| Novolog Flexpen Insulin Aspart | 193 | 380 | 62 | $74K |
| Methimazole Generic | 156 | 362 | 36 | $2,622 |
| Jardiance Empagliflozin | 150 | 306 | 37 | $170K |
| Trulicity Dulaglutide | 126 | 181 | 28 | $170K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 97 | 234 | 36 | $13K |
| Novolin N Flexpen Insulin Nph Human Isophane | 95 | 216 | 27 | $18K |
| Humalog Kwikpen U-100 Insulin Lispro | 84 | 196 | 38 | $30K |
| Novolog Insulin Aspart | 82 | 164 | 25 | $24K |
| Synthroid Levothyroxine Sodium | 81 | 218 | 22 | $5,210 |
| Metformin Hcl Generic | 70 | 198 | 25 | $357 |
| Novolin N Insulin Nph Human Isophane | 64 | 120 | 19 | $12K |
| Alendronate Sodium Generic | 63 | 153 | 17 | $397 |
Brand drugs: 2,108 claims; generic drugs: 1,272 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Alpa P Patel $18.52 ($18.52 in general payments such as food, travel and fees) from 1 company. The largest payer was Novo Nordisk Inc with $18.52.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 1 | $18.52 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.